Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$825.45
4.410.54%
al cierre: -
$826.01
0.560.07%
After hour: Oct 24, 6:48 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Eli Lilly Corp tiene un precio objetivo de consenso de $567,61 según las calificaciones de 38 analistas. El máximo es de $1350 emitido por HSBC el 10 de mayo de 2024. El mínimo es de $100 emitido por Deutsche Bank el 5 de agosto de 2024. Las 3 calificaciones de analistas más recientes fueron publicadas por New Street Research, Goldman Sachs y Deutsche Bank el 6 de agosto de 2024, el 5 de agosto de 2024 y el 5 de agosto de 2024, respectivamente. Con un precio objetivo promedio de $118,33 entre New Street Research, Goldman Sachs y Deutsche Bank, hay un alza implícita del 0,21 % para Eli Lilly Corp a partir de estas calificaciones de analistas más recientes.
Firmas de analistas que realizan recomendaciones1
Guggenheim
Morgan Stanley
Berenberg
JP Morgan
HSBC
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Eli Lilly
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/16/2025 | — | Guggenheim | $948 → $948 | Reiterates | Buy → Buy | |||
10/08/2025 | — | Guggenheim | $875 → $948 | Maintains | Buy | |||
10/03/2025 | — | Morgan Stanley | $1028 → $1023 | Maintains | Overweight | |||
09/17/2025 | — | Berenberg | $970 → $830 | Downgrade | Buy → Hold | |||
09/16/2025 | — | JP Morgan | $1100 → $1050 | Maintains | Overweight | |||
08/27/2025 | — | HSBC | $675 → $700 | Upgrade | Reduce → Hold | |||
08/13/2025 | — | Cantor Fitzgerald | $975 → $825 | Maintains | Overweight | |||
08/13/2025 | — | Guggenheim | $942 → $875 | Maintains | Buy | |||
08/11/2025 | — | Deutsche Bank | $1010 → $900 | Maintains | Buy | |||
08/08/2025 | — | JP Morgan | $1100 → $1100 | Reiterates | Overweight → Overweight | |||
08/08/2025 | — | UBS | $1050 → $895 | Maintains | Buy | |||
07/11/2025 | — | Guggenheim | $936 → $942 | Maintains | Buy | |||
07/10/2025 | — | Morgan Stanley | $1133 → $1135 | Maintains | Overweight | |||
06/20/2025 | — | Guggenheim | $936 → $936 | Reiterates | Buy → Buy | |||
05/02/2025 | — | UBS | $1100 → $1050 | Maintains | Buy | |||
04/28/2025 | — | HSBC | $1150 → $700 | Downgrade | Buy → Reduce | |||
04/22/2025 | — | Cantor Fitzgerald | → $975 | Initiates | → Overweight | |||
04/14/2025 | — | Guggenheim | $973 → $928 | Maintains | Buy | |||
04/09/2025 | — | Morgan Stanley | $1146 → $1124 | Maintains | Overweight | |||
04/08/2025 | — | Goldman Sachs | $892 → $888 | Upgrade | Neutral → Buy | |||
03/05/2025 | — | Wells Fargo | $970 → $1100 | Maintains | Overweight | |||
02/03/2025 | — | Truist Securities | $1029 → $1038 | Maintains | Buy | |||
01/28/2025 | — | Wells Fargo | $1000 → $970 | Maintains | Overweight | |||
01/28/2025 | — | Citigroup | $1250 → $1190 | Maintains | Buy | |||
12/10/2024 | — | B of A Securities | → $997 | Reinstates | → Buy | |||
11/15/2024 | — | Wolfe Research | → $1000 | Initiates | → Outperform | |||
11/04/2024 | — | Deutsche Bank | $1025 → $1015 | Maintains | Buy | |||
10/31/2024 | — | Truist Securities | $1033 → $1029 | Maintains | Buy | |||
10/31/2024 | — | Barclays | $1025 → $975 | Maintains | Overweight | |||
10/31/2024 | — | B of A Securities | $1150 → $1100 | Maintains | Buy | |||
10/25/2024 | — | Citigroup | $1060 → $1250 | Maintains | Buy | |||
10/17/2024 | — | Bernstein | — | → $1100 | Initiates | → Outperform | ||
10/10/2024 | — | Truist Securities | $1000 → $1033 | Maintains | Buy | |||
10/03/2024 | — | Deutsche Bank | $1025 → $1025 | Reiterates | Buy → Buy | |||
09/16/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
09/13/2024 | — | JP Morgan | $1050 → $1100 | Maintains | Overweight | |||
09/13/2024 | — | Citigroup | → $1060 | Reinstates | Buy → Buy | |||
09/09/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
08/27/2024 | — | Morgan Stanley | $1106 → $1106 | Reiterates | Overweight → Overweight | |||
08/19/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
08/16/2024 | — | Guggenheim | $884 → $1030 | Maintains | Buy | |||
08/14/2024 | — | Berenberg | $1000 → $1050 | Maintains | Buy | |||
08/12/2024 | — | Deutsche Bank | $725 → $1025 | Upgrade | Hold → Buy | |||
08/09/2024 | — | Wells Fargo | $875 → $1000 | Maintains | Overweight | |||
08/09/2024 | — | BMO Capital | $1001 → $1101 | Maintains | Outperform | |||
08/09/2024 | — | B of A Securities | $1000 → $1125 | Maintains | Buy | |||
08/05/2024 | — | Guggenheim | $855 → $884 | Maintains | Buy | |||
08/05/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
07/24/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
07/15/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
07/11/2024 | — | Berenberg | $850 → $1000 | Maintains | Buy | |||
07/11/2024 | — | JP Morgan | $900 → $1000 | Maintains | Overweight | |||
07/10/2024 | — | Barclays | $913 → $1025 | Maintains | Overweight | |||
07/05/2024 | — | Morgan Stanley | $1023 → $1023 | Maintains | Overweight | |||
07/03/2024 | — | BMO Capital | $1001 → $1001 | Maintains | Outperform | |||
07/01/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
06/26/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
06/25/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
06/25/2024 | — | Truist Securities | $892 → $1000 | Reiterates | Buy → Buy | |||
06/24/2024 | — | Jefferies | $994 → $1015 | Maintains | Buy | |||
06/24/2024 | — | B of A Securities | $1000 → $1000 | Maintains | Buy | |||
06/24/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
06/20/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
06/17/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
06/12/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
06/11/2024 | — | Cantor Fitzgerald | $885 → $885 | Reiterates | Overweight → Overweight | |||
06/07/2024 | — | Jefferies | $925 → $957 | Maintains | Buy | |||
05/14/2024 | — | Argus Research | $770 → $840 | Maintains | Buy | |||
05/01/2024 | — | BMO Capital | $900 → $1001 | Maintains | Outperform | |||
05/01/2024 | — | JP Morgan | $850 → $900 | Maintains | Overweight | |||
05/01/2024 | — | Cantor Fitzgerald | $815 → $885 | Maintains | Overweight | |||
05/01/2024 | — | Truist Securities | $850 → $892 | Maintains | Buy | |||
04/30/2024 | — | Cantor Fitzgerald | $815 → $885 | Reiterates | Overweight → Overweight | |||
04/18/2024 | — | Cantor Fitzgerald | $815 → $815 | Reiterates | Overweight → Overweight | |||
04/15/2024 | — | Cantor Fitzgerald | $815 → $815 | Reiterates | Overweight → Overweight | |||
04/11/2024 | — | Goldman Sachs | $650 → $723 | Maintains | Neutral | |||
04/05/2024 | — | Cantor Fitzgerald | $815 → $815 | Reiterates | Overweight → Overweight | |||
04/03/2024 | — | Erste Group | — | Upgrade | Hold → Buy | |||
04/02/2024 | — | Citigroup | $675 → $895 | Maintains | Buy | |||
04/01/2024 | — | Cantor Fitzgerald | $815 → $815 | Reiterates | Overweight → Overweight | |||
03/22/2024 | — | Truist Securities | → $850 | Reiterates | Buy → Buy | |||
03/15/2024 | — | JP Morgan | $775 → $850 | Maintains | Overweight | |||
03/01/2024 | — | B of A Securities | $800 → $1000 | Maintains | Buy | |||
02/21/2024 | — | DZ Bank | → $820 | Downgrade | Buy → Hold | |||
02/20/2024 | — | Cantor Fitzgerald | $815 → $815 | Reiterates | Overweight → Overweight | |||
02/16/2024 | — | Morgan Stanley | $805 → $950 | Maintains | Overweight | |||
02/14/2024 | — | Cantor Fitzgerald | $815 → $815 | Reiterates | Overweight → Overweight | |||
02/07/2024 | — | Barclays | $680 → $810 | Maintains | Overweight | |||
02/07/2024 | — | Truist Securities | $650 → $850 | Maintains | Buy | |||
02/07/2024 | — | Morgan Stanley | $763 → $805 | Maintains | Overweight | |||
02/07/2024 | — | Wells Fargo | $700 → $825 | Maintains | Overweight | |||
02/07/2024 | — | BMO Capital | $710 → $865 | Maintains | Outperform | |||
02/06/2024 | — | Wells Fargo | $700 → $825 | Maintains | Overweight | |||
02/06/2024 | — | Cantor Fitzgerald | $630 → $815 | Maintains | Overweight | |||
02/05/2024 | — | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight | |||
02/01/2024 | — | Cantor Fitzgerald | $630 → $630 | Reiterates | Overweight → Overweight | |||
01/24/2024 | — | Wells Fargo | $650 → $700 | Maintains | Overweight | |||
01/23/2024 | — | Cantor Fitzgerald | $630 → $630 | Reiterates | Overweight → Overweight | |||
01/23/2024 | — | Barclays | $630 → $680 | Maintains | Overweight | |||
12/21/2023 | — | Daiwa Capital | → $610 | Downgrade | Buy → Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Eli Lilly (LLY)?
El último precio objetivo de Eli Lilly (NYSE:LLY) fue comunicado por Guggenheim el octubre 16, 2025. La firma de analistas fijó un precio objetivo para $948.00 que espera LLY a rise dentro de 12 meses (un posible 14.77% upside). 30 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Eli Lilly (LLY)?
La última calificación de analistas para Eli Lilly (NYSE:LLY) fue proporcionada por Guggenheim, y Eli Lilly reiterado su buy calificación.
¿Cuándo se produjo la última revisión al alza de Eli Lilly (LLY)?
La última revisión al alza de Eli Lilly and Co se produjo en agosto 27, 2025, cuando HSBC elevó su precio objetivo a $700. HSBC anteriormente tenía a reduce para Eli Lilly and Co.
¿Cuándo fue la última revisión a la baja de Eli Lilly (LLY)?
La última revisión a la baja de Eli Lilly and Co se produjo en septiembre 17, 2025, cuando Berenberg cambió su precio objetivo de $970 a $830 para Eli Lilly and Co.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Eli Lilly (LLY)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Eli Lilly, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Eli Lilly se registró el octubre 16, 2025, por lo que la próxima calificación estará disponible en torno al octubre 16, 2026.
¿Es correcta la calificación de los analistas sobre Eli Lilly (LLY)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Eli Lilly (LLY) fue un reiterado con un precio objetivo de $948.00 a $948.00. El precio actual al que cotiza Eli Lilly (LLY) es de $826.01, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.